Ftse Mib
34.083,91
0,75%
DAX
20.232,14
0,98%
S&P 500
6.086,49
0,61%
NASDAQ
19.735,12
1,30%
Bitcoin
98.543,75
-0,22%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Outlook Therapeutics Inc (OTLK) Outlook Therapeutics Inc (OTLK) Notizie

Outlook Therapeutics Inc

OTLK
1,61
-0,195 (-10,80%)
05 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/12/202414:05GLOBEOutlook Therapeutics® Announces NICE Recommendation of..
04/12/202413:27EDGAR2Form 8-K - Current report
03/12/202422:30GLOBEOutlook Therapeutics® Announces Executive Leadership..
27/11/202418:26EDGAR2Form 8-K - Current report
27/11/202412:50GLOBEOutlook Therapeutics® Announces Preliminary Topline Results..
06/11/202414:05GLOBEOutlook Therapeutics® to Present at the Guggenheim..
17/10/202415:00GLOBEOutlook Therapeutics® Participates in a Virtual Investor CEO..
04/10/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202414:05GLOBEOutlook Therapeutics® to Participate in the Virtual Investor..
13/9/202415:05GLOBEOutlook Therapeutics® Participates in the 2nd Annual Chardan..
04/9/202414:35GLOBEOutlook Therapeutics® Announces Completion of Enrollment in..
03/9/202414:45GLOBEOutlook Therapeutics® to Present at the H.C. Wainwright 26th..
14/8/202422:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202413:48EDGAR2Form 8-K - Current report
14/8/202413:05GLOBEOutlook Therapeutics® Reports Financial Results for Third..
12/8/202415:05GLOBEOutlook Therapeutics® to Present at the H.C. Wainwright 4th..
07/8/202414:35GLOBEOutlook Therapeutics® to Report Financial Results for Third..
30/7/202415:10GLOBEOutlook Therapeutics® to Present at the BTIG Virtual..
08/7/202414:41EDGAR2Form 8-K - Current report
08/7/202414:35GLOBEOutlook Therapeutics® Announces UK MHRA Marketing..
14/6/202422:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/6/202415:05GLOBEOutlook Therapeutics® to Present at the Virtual Investor..
28/5/202414:05GLOBEOutlook Therapeutics® Receives European Commission Marketing..
15/5/202423:19EDGAR2Form 8-K - Current report
15/5/202423:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202423:00GLOBEOutlook Therapeutics® Reports Financial Results for Second..
13/5/202422:05EDGAR2Form 8-K - Current report
13/5/202414:50GLOBEOutlook Therapeutics® Announces UK Submission of Marketing..
09/5/202414:45GLOBEOutlook Therapeutics® to Report Financial Results for Second..
07/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/5/202422:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202415:05GLOBEOutlook Therapeutics® to Present at the Retina World..
29/4/202415:00GLOBEOutlook Therapeutics® to Present at the Ophthalmology..
15/4/202422:15GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
22/3/202412:35GLOBEOutlook Therapeutics® Receives European Union Positive CHMP..
18/3/202422:10GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
12/3/202413:05GLOBEOutlook Therapeutics® Announces Effective Date for 1-for-20..
11/3/202421:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:16EDGAR2Form 8-K - Current report
14/2/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202422:40EDGAR2Form 8-K - Current report
14/2/202414:05GLOBEOutlook Therapeutics® Reports Financial Results for First..
Apertura: 1,85 Min: 1,59 Max: 1,85
Chiusura: 1,805

La tua Cronologia

NASDAQ
OTLK
Outlook Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network